MARKET

CBIO

CBIO

Crescent Biopharma Inc
NASDAQ
18.52
-0.24
-1.28%
After Hours: 18.52 0 0.00% 16:10 05/11 EDT
OPEN
18.72
PREV CLOSE
18.76
HIGH
19.81
LOW
17.68
VOLUME
549.55K
TURNOVER
--
52 WEEK HIGH
27.50
52 WEEK LOW
8.72
MARKET CAP
510.63M
P/E (TTM)
-1.5026
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at CBIO last week (0504-0508)?
Weekly Report · 11h ago
Crescent Biopharma to present at BofA Securities healthcare conference
PUBT · 5d ago
Crescent Biopharma to Present at May Investor Conferences
Barchart · 5d ago
Analysts Are Bullish on Top Healthcare Stocks: Tonix Pharma (TNXP), Crescent Biopharma (CBIO)
TipRanks · 05/04 10:40
Weekly Report: what happened at CBIO last week (0427-0501)?
Weekly Report · 05/04 09:44
Nasdaq Jumps Over 1%; Exxon Mobil Posts Upbeat Revenue
Benzinga · 05/01 18:15
Crescent Biopharma Down Over 16%, On Pace for Largest Percent Decrease Since July 2024 -- Data Talk
Dow Jones · 05/01 15:58
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga · 05/01 12:05
More
About CBIO
Crescent Biopharma, Inc. is a biotechnology company. The Company is focused on advancing the next wave of therapies for cancer patients. The Company’s pipeline includes its lead program, a PD-1 x VEGF bispecific antibody, as well as novel antibody-drug conjugates. The Company’s lead program is CR-001, a tetravalent PD-1 x VEGF bispecific antibody in development for the treatment of solid tumors, and it is also advancing CR-002 and CR-003, antibody drug conjugates (ADCs) with topoisomerase inhibitor payloads. CR-002 and CR-003 are ADCs designed to deliver clinically active cytotoxic drugs known as topoisomerase inhibitors to tumor cells. Each of these programs has the potential to deliver therapeutics with clinical efficacy both as a monotherapy and in combination with CR-001 with significant potential across solid tumor indications.

Webull offers Crescent Biopharma Inc stock information, including NASDAQ: CBIO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CBIO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CBIO stock methods without spending real money on the virtual paper trading platform.